Surendra Kumar Nayak

2.5k total citations · 1 hit paper
53 papers, 1.9k citations indexed

About

Surendra Kumar Nayak is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Surendra Kumar Nayak has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Surendra Kumar Nayak's work include Synthesis and biological activity (6 papers), Chemical and Physical Properties in Aqueous Solutions (6 papers) and Cancer-related Molecular Pathways (5 papers). Surendra Kumar Nayak is often cited by papers focused on Synthesis and biological activity (6 papers), Chemical and Physical Properties in Aqueous Solutions (6 papers) and Cancer-related Molecular Pathways (5 papers). Surendra Kumar Nayak collaborates with scholars based in India, United States and Afghanistan. Surendra Kumar Nayak's co-authors include Satchidananda Panda, Timothy Jegla, Brice Campo, John R. Walker, John B. Hogenesch, Megumi Hatori, Inder M. Verma, Rajesh Narasimamurthy, Fei Liu and Gopal L. Khatik and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Surendra Kumar Nayak

51 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review

2021 208 citations Surendra Kumar Nayak et al. profile →

Peers

Countries citing papers authored by Surendra Kumar Nayak

Since Specialization

Citations

This map shows the geographic impact of Surendra Kumar Nayak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surendra Kumar Nayak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surendra Kumar Nayak more than expected).

Fields of papers citing papers by Surendra Kumar Nayak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surendra Kumar Nayak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surendra Kumar Nayak. The network helps show where Surendra Kumar Nayak may publish in the future.

Co-authorship network of co-authors of Surendra Kumar Nayak

This figure shows the co-authorship network connecting the top 25 collaborators of Surendra Kumar Nayak. A scholar is included among the top collaborators of Surendra Kumar Nayak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surendra Kumar Nayak. Surendra Kumar Nayak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus 2019 ·Current Diabetes Reviews ·(unknown), Manish Vyas, Surendra Kumar Nayak, Ashish Suttee, Surajpal Verma, Rakesh Narang, Gopal L. Khatik	56
2	Recent advancements in mechanistic studies and structure activity relationship of FoF1 ATP synthase inhibitor as antimicrobial agent 2019 ·European Journal of Medicinal Chemistry ·Rakesh Narang, Raj Kumar, Sourav Kalra, Surendra Kumar Nayak, Gopal L. Khatik, (unknown), Kalvatala Sudhakar, Sachin Kumar Singh	26
3	Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus 2018 ·Current Drug Targets ·Paranjeet Kaur, Amit Mittal, Surendra Kumar Nayak, Manish Vyas, Vijay Mishra, Gopal L. Khatik	29
4	Melanopsin-Encoded Response Properties of Intrinsically Photosensitive Retinal Ganglion Cells 2016 ·Neuron ·Ludovic S. Mure, Megumi Hatori, Quansheng Zhu, (unknown), (unknown), Surendra Kumar Nayak, Satchidananda Panda	38
5	ADVANCEMENT IN LITHIUM PERCHLORATE CATALYZED SYNTHESIS OF ORGANIC MOLECULAR SCAFFOLDS 2015 ·International Journal of Pharma and Bio Sciences ·(unknown), Rakesh Narang, Surendra Kumar Nayak	0
6	(R,R′)-4′-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility 2013 ·Biochemical Pharmacology ·Rajib Paul, Artur Wnorowski, Isabel González‐Mariscal, Surendra Kumar Nayak, (unknown), Ruin Moaddel, Fred E. Indig, Michel Bernier, Irving W. Wainer	18
7	Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines 2012 ·Proceedings of the National Academy of Sciences ·Rajesh Narasimamurthy, Megumi Hatori, Surendra Kumar Nayak, Fei Liu, Satchidananda Panda, Inder M. Verma	337
8	Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future 2011 ·Current Medicinal Chemistry ·Surendra Kumar Nayak, Parmjit S. Panesar, (unknown)	5
9	p53-Induced Apoptosis and Inhibitors of p53 2009 ·Current Medicinal Chemistry ·Surendra Kumar Nayak, Parmjit S. Panesar, Harish Kumar	32
10	Evolution of the Human Ion Channel Set 2009 ·Combinatorial Chemistry & High Throughput Screening ·Surendra Kumar Nayak, Serge Batalov, Timothy Jegla, Christian M. Zmasek	85
11	Role of a novel photopigment, melanopsin, in behavioral adaptation to light 2006 ·Cellular and Molecular Life Sciences ·Surendra Kumar Nayak, Timothy Jegla, Satchidananda Panda	41
12	Illumination of the Melanopsin Signaling Pathway 2005 ·Science ·Satchidananda Panda, Surendra Kumar Nayak, Brice Campo, John R. Walker, John B. Hogenesch, Timothy Jegla	379
13	Illumination of the Melanopsin Signaling Cascade 2005 ·Investigative Ophthalmology & Visual Science ·(unknown), Surendra Kumar Nayak, Brice Campo, John R. Walker, John B. Hogenesch, Timothy Jegla	1
14	Gβγ Inhibits Gα GTPase-activating Proteins by Inhibition of Gα-GTP Binding during Stimulation by Receptor 2005 ·Journal of Biological Chemistry ·Wei Tang, Yaping Tu, Surendra Kumar Nayak, (unknown), (unknown), Elliott M. Ross	32
15	Homer 2 tunes G protein–coupled receptors stimulus intensity by regulating RGS proteins and PLCβ GAP activities 2003 ·The Journal of Cell Biology ·Dong Min Shin, Marlin H. Dehoff, Xiang Luo, Shin Hyeok Kang, (unknown), Surendra Kumar Nayak, Elliott M. Ross, Paul Worley, Shmuel Muallem	80
16	Phosphorylation-regulated Inhibition of the Gz GTPase-activating Protein Activity of RGS Proteins by Synapsin I 2003 ·Journal of Biological Chemistry ·Yaping Tu, Surendra Kumar Nayak, (unknown), Elliott M. Ross	14
17	Infarction of acinic cell carcinoma in a patient infected with HIV: A complication of fine‐needle aspiration cytology obscuring definitive diagnosis 2003 ·Diagnostic Cytopathology ·(unknown), (unknown), Surendra Kumar Nayak	3
18	Localization of the catalytic activity in restrictocin molecule by deletion mutagenesis 2000 ·European Journal of Biochemistry ·Surendra Kumar Nayak, (unknown), Janendra K. Batra	3
19	Overproduction of fungal ribotoxin α-sarcin in Escherichia coli: generation of an active immunotoxin 1997 ·Gene ·Dharmendar Rathore, Surendra Kumar Nayak, Janendra K. Batra	18
20	Expression of ribonucleolytic toxin restrictocin in Escherichia coli: purification and characterization 1996 ·FEBS Letters ·Dharmendar Rathore, Surendra Kumar Nayak, Janendra K. Batra	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact